Autoantibodies in celiac disease

References

• Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383–391
   PubMed Web of Science ®Google Scholar
• Alaedini A, Green PH. Narrative review: Celiac disease: Understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: 289–298
   PubMed Web of Science ®Google Scholar
• Rubin W, Fauci AS, Marvin SF, Sleisenger MH, Jefries GH. Immunofluorescent studies in adult celiac disease. J Clin Invest 1965; 44: 475–485
   PubMed Web of Science ®Google Scholar
• Malik GB, Watson WC, Murray D, Cruickshank B. Immunofluorescent antibody studies in idiopathic steatorrhoea. Lancet 1964; 13: 1127–1129
   Google Scholar
• Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801
   PubMed Web of Science ®Google Scholar
• Korponay-Szabo IR, Laurila K, Szondy Z, et al. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues. Gut 2003; 52: 199–204
   PubMed Web of Science ®Google Scholar
• Korponay-Szabo IR, Sulkanen S, Halttunen T, et al. Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies. J Pediatr Gastroenterol Nutr 2000; 31: 520–527
   PubMed Web of Science ®Google Scholar
• Lorand L, Conrad SM. Transglutaminases. Mol Cell Biochem 1984; 58: 9–35
   PubMed Web of Science ®Google Scholar
• Folk JE, Chung SI. Transglutaminases. Methods Enzymol 1985; 113: 358–375
   PubMed Web of Science ®Google Scholar
• Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5–19
   PubMed Web of Science ®Google Scholar
• Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53–81
   PubMed Web of Science ®Google Scholar
• Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713–717
   PubMed Web of Science ®Google Scholar
• Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002; 55: 488–494
   PubMed Web of Science ®Google Scholar
• Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999; 45: 2142–2149
   PubMed Web of Science ®Google Scholar
• Clemente MG, Musu MP, Frau F, Lucia C, De Virgiliis S. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 2002; 34: 31–34
   PubMed Web of Science ®Google Scholar
• Carroccio A, Giannitrapani L, Soresi M, et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut 2001; 49: 506–511
   PubMed Web of Science ®Google Scholar
• Rostom ADC, Cranney A, Saloojee N, Sy R, et al. Celiac disease Evidence report/Technology assessment no. 104. Agency for Healthcare Research and Quality Publication no. 04-E029-2 2004.
   Google Scholar
• Rostom A, Murray JA, Kagnoff MF. American gastroenterological association (AGA) institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981–2002
   PubMed Web of Science ®Google Scholar
• Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909–911
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003; 36: 219–221
   PubMed Web of Science ®Google Scholar
• Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888–894
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Lichtenfeld J, Osman AA, Richter T, Mothes T. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Eur J Gastroenterol Hepatol 2000; 12: 1017–1020
   PubMed Web of Science ®Google Scholar
• Brusco G, Muzi P, Ciccocioppo R, Biagi F, Cifone MG, Corazza GR. Transglutaminase and coeliac disease: Endomysial reactivity and small bowel expression. Clin Exp Immunol 1999; 118: 371–375
   PubMed Web of Science ®Google Scholar
• Lock RJ, Gilmour JE, Unsworth DJ. Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies-the antibody trinity of coeliac disease. Clin Exp Immunol 1999; 116(2)258–262
   PubMed Web of Science ®Google Scholar
• Griffin M, Casadio R, Bergamini CM. Transglutaminases: Nature's biological glues. Biochem J 2002; 368: 377–396
   PubMed Web of Science ®Google Scholar
• Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747–757
   PubMed Web of Science ®Google Scholar
• Donaldson MR, Zone JJ, Schmidt LA, et al. Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis. J Invest Dermatol 2007; 127: 1268–1271
   PubMed Web of Science ®Google Scholar
• Sjober K, Eriksson S, Tenngart B, Roth EB, Leffler H, Stenberg P. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Autoimmunity 2002; 35(5)357–364
   PubMed Web of Science ®Google Scholar
• Clemente MG, Musu MP, Frau F, et al. Immune reaction against the cytoskeleton in coeliac disease. Gut 2000; 47: 520–526
   PubMed Web of Science ®Google Scholar
• Stulik J, Hernychova L, Porkertova S, et al. Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 2003; 3(6)951–956
   PubMed Web of Science ®Google Scholar
• Pedreira S, Sugai E, Moreno ML, et al. Significance of smooth muscle/anti-actin autoantibodies in celiac disease. Acta Gastroenterol Latinoam 2005; 35: 83–93
   PubMedGoogle Scholar
• Carroccio A, Fabiani E, Iannitto E, et al. Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma. Case reports. Digestion 2000; 62: 271–275
   PubMed Web of Science ®Google Scholar
• Lidman K, Biberfeld G, Fagraeus A, et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 1976; 24: 266–272
   PubMed Web of Science ®Google Scholar
• Krupickova S, Tuckova L, Flegelova Z, et al. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut 1999; 44: 168–173
   PubMed Web of Science ®Google Scholar
• Bailey DS, Freedman AR, Price SC, Chescoe D, Ciclitira PJ. Early biochemical responses of the small intestine of coeliac patients to wheat gluten. Gut 1989; 30: 78–85
   PubMed Web of Science ®Google Scholar
• Alaedini A, Green PH, Sander HW, et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol 2002; 127: 145–148
   PubMed Web of Science ®Google Scholar
• Shill HA, Alaedini A, Latov N, Hallett M. Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration. Neurology 2003; 60: 1672–1673
   PubMed Web of Science ®Google Scholar
• Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology 2003; 60: 1581–1585
   PubMed Web of Science ®Google Scholar
• Volta U, De Giorgio R, Granito A, et al. Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis 2006; 38: 183–187
   PubMedGoogle Scholar
• Sato E, Uezato T, Fujita M, Nishimura K. Developmental profiles of glycolipids in mouse small intestine. J Biochem (Tokyo) 1982; 91: 2013–2019
   PubMed Web of Science ®Google Scholar
• Hansson HA, Holmgren J, Svennerholm L. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci USA 1977; 74: 3782–3786
   PubMed Web of Science ®Google Scholar
• O'Leary CP, Willison HJ. The role of antiglycolipid antibodies in peripheral neuropathies. Curr Opin Neurol 2000; 13: 583–588
   PubMed Web of Science ®Google Scholar
• Alaedini A, Briani C, Wirguin I, Siciliano G, D'Avino C, Latov N. Detection of anti-ganglioside antibodies in Guillain-Barre syndrome and its variants by the agglutination assay. J Neurol Sci 2002; 196: 41–44
   PubMed Web of Science ®Google Scholar
• Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355: 1518–1519
   PubMed Web of Science ®Google Scholar
• Lerner A, Blank M, Lahat N, Shoenfeld Y. Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci 1998; 43: 723–726
   PubMed Web of Science ®Google Scholar
• Sanchez D, Tuckova L, Mothes T, Kreisel W, Benes Z, Tlaskalova-Hogenova H. Epitopes of calreticulin recognised by IgA autoantibodies from patients with hepatic and coeliac disease. J Autoimmun 2003; 21: 383–392
   PubMed Web of Science ®Google Scholar
• Sanchez D, Tuckova L, Sebo P, et al. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases. J Autoimmun 2000; 15(4)441–449
   PubMed Web of Science ®Google Scholar
• Alaedini A, Okamoto H, Briani C. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neural synapsin I. J Immunol 2007; 178: 6590–6595
   PubMed Web of Science ®Google Scholar
• Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464–483
   PubMed Web of Science ®Google Scholar
• Dalton TA, Bennett JC. Autoimmune disease and the major histocompatibility complex: Therapeutic implications. Am J Med 1992; 92: 183–188
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221–229
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Quattrocchi CC, Nistico L. Dissecting the genetics of type 1 diabetes: Relevance for familial clustering and differences in incidence. Diabetes Metab Rev 1998; 14: 111–128
   PubMed Web of Science ®Google Scholar
• Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000; 137: 263–265
   PubMed Web of Science ®Google Scholar
• Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322–1328
   PubMed Web of Science ®Google Scholar
• Dieterich W, Esslinger B, Trapp D, et al. Crosslinking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 2006; 55: 478–484
   PubMed Web of Science ®Google Scholar
• Alaedini A, Latov N. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside. J Neuroimmunol 2006; 177: 167–172
   PubMed Web of Science ®Google Scholar
• Corthay A, Backlund J, Holmdahl R. Role of glycopeptide-specific T cells in collagen-induced arthritis: An example how post-translational modification of proteins may be involved in autoimmune disease. Ann Med 2001; 33: 456–465
   PubMed Web of Science ®Google Scholar
• Doyle HA, Mamula MJ. Posttranslational protein modifications: New flavors in the menu of autoantigens. Curr Opin Rheumatol 2002; 14: 244–249
   PubMed Web of Science ®Google Scholar
• Pender SL, Tickle SP, Docherty AJ, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997; 158: 1582–1590
   PubMed Web of Science ®Google Scholar
• Daum S, Bauer U, Foss HD, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 1999; 44: 17–25
   PubMed Web of Science ®Google Scholar
• Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: The Yin and Yang of celiac disease. Immunol Rev 2005; 206: 219–231
   PubMed Web of Science ®Google Scholar
• Lundqvist C, Melgar S, Yeung MM, Hammarstrom S, Hammarstrom ML. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol 1996; 157: 1926–1934
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer AJ, Radaszkiewicz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol 1996; 148: 1351–1357
   PubMed Web of Science ®Google Scholar
• Hue S, Mention JJ, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21: 367–377
   PubMed Web of Science ®Google Scholar
• Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362: 30–37
   PubMed Web of Science ®Google Scholar
• Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21: 357–366
   PubMed Web of Science ®Google Scholar
• Gianfrani C, Troncone R, Mugione P, et al. Celiac disease association with CD8+T cell responses: Identification of a novel gliadin-derived HLA-A2-restricted epitope. J Immunol 2003; 170: 2719–2726
   PubMed Web of Science ®Google Scholar
• Sblattero D, Florian F, Azzoni E, et al. The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem 2002; 269: 5175–5181
   PubMedGoogle Scholar
• Esposito C, Paparo F, Caputo I, et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002; 51: 177–181
   PubMed Web of Science ®Google Scholar
• Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997; 136: 1151–1163
   PubMed Web of Science ®Google Scholar
• Halttunen T, Marttinen A, Rantala I, Kainulainen H, Maki M. Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology 1996; 111: 1252–1262
   PubMed Web of Science ®Google Scholar
• Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta. Gastroenterology 1993; 105: 1323–1332
   PubMed Web of Science ®Google Scholar
• Halttunen T, Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999; 116: 566–572
   PubMed Web of Science ®Google Scholar
• Zanoni G, Navone R, Lunardi C, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006; 3: e358
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou M, Maki M, Sanders DS, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006; 66: 373–377
   PubMed Web of Science ®Google Scholar
• Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: The KORA/MONICA augsburg cohort study 1989–1998. Eur J Epidemiol 2006; 21: 359–365
   PubMed Web of Science ®Google Scholar
• Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001; 49: 712–720
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Hitoshi S, Kaida K, Murayama S, Kanazawa I. Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum. Neurosci Lett 1999; 273: 33–36
   PubMed Web of Science ®Google Scholar
• Takigawa T, Yasuda H, Terada M, et al. The sera from GM1 ganglioside antibody positive patients with Guillain-Barre syndrome or chronic inflammatory demyelinating polyneuropathy blocks Na+ currents in rat single myelinated nerve fibers. Intern Med 2000; 39: 123–127
   PubMed Web of Science ®Google Scholar
• Buchwald B, Ahangari R, Toyka KV. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neurosci Lett 2002; 334: 25–28
   PubMed Web of Science ®Google Scholar
• Tuckova L, Karska K, Walters JR, et al. Anti-gliadin antibodies in patients with celiac disease cross-react with enterocytes and human calreticulin. Clin Immunol Immunopathol 1997; 85: 289–296
   PubMedGoogle Scholar
• Tursi A, Giorgetti GM, Iani C, et al. Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet. Dig Dis Sci 2006; 51: 1869–1874
   PubMed Web of Science ®Google Scholar